Rhenman & Partners Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Rhenman & Partners Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,060,000	Closed	-$5.19M	–	104
2019 Q3	$5.19M	Sell	1,060,000 -143,405	-12%	-$802K	0.65%	56
2019 Q2	$7.33M	Hold	1,203,405	–	–	0.81%	50
2019 Q1	$6.99M	Hold	1,203,405	–	–	0.82%	51
2018 Q4	$16.2M	Buy	1,203,405 +28,994	+2%	+$489K	1.85%	21
2018 Q3	$22.8M	Buy	1,174,411 +1,032,047	+725%	+$22M	2.28%	10
2018 Q2	$3.64M	Buy	+142,364	New	+$3.32M	0.37%	65

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rhenman & Partners Asset Management's DPLO Position: Q4 2019 in Review

Rhenman & Partners Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 1,060,000 shares — an estimated $5.19M sold.

Rhenman & Partners Asset Management first reported a position in DPLO in Q2 2018 and held it in 6 quarters. The position peaked at $22.8M in Q3 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

Rhenman & Partners Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
Rhenman & Partners Asset Management sold 1,060,000 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $5.19M.
Rhenman & Partners Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2018 and held it in 6 quarters.
Rhenman & Partners Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $22.8M in Q3 2018.
138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.